Ashili S - Search Results

1

Activity of pemetrexed in pre-clinical chordoma models and humans.

Kesari S, Wang F, Juarez T, Ashili S, Patro CPK, Carrillo J, Nguyen M, Truong J, Levy J, Sommer J, Freed DM, Xiu J, Takasumi Y, Bouffet E, Gill JM. Kesari S, et al. Among authors: ashili s. Sci Rep. 2023 May 5;13(1):7317. doi: 10.1038/s41598-023-34404-4. Sci Rep. 2023. PMID: 37147496 Free PMC article.

2

Platform for combined analysis of functional and biomolecular phenotypes of the same cell.

Kelbauskas L, Ashili S, Zeng J, Rezaie A, Lee K, Derkach D, Ueberroth B, Gao W, Paulson T, Wang H, Tian Y, Smith D, Reid B, Meldrum DR. Kelbauskas L, et al. Among authors: ashili s. Sci Rep. 2017 Mar 16;7:44636. doi: 10.1038/srep44636. Sci Rep. 2017. PMID: 28300162 Free PMC article.

3

Simultaneous Multiparameter Cellular Energy Metabolism Profiling of Small Populations of Cells.

Kelbauskas L, Ashili SP, Lee KB, Zhu H, Tian Y, Meldrum DR. Kelbauskas L, et al. Sci Rep. 2018 Mar 12;8(1):4359. doi: 10.1038/s41598-018-22599-w. Sci Rep. 2018. PMID: 29531352 Free PMC article.

4

Spinal Muscular Atrophy: Current Medications and Re-purposed Drugs.

Basak S, Biswas N, Gill J, Ashili S. Basak S, et al. Among authors: ashili s. Cell Mol Neurobiol. 2024 Nov 8;44(1):75. doi: 10.1007/s10571-024-01511-3. Cell Mol Neurobiol. 2024. PMID: 39514016 Free PMC article. Review.

5

Repurposing metabolic regulators: antidiabetic drugs as anticancer agents.

Dhas Y, Biswas N, M R D, Jones LD, Ashili S. Dhas Y, et al. Among authors: ashili s. Mol Biomed. 2024 Sep 28;5(1):40. doi: 10.1186/s43556-024-00204-z. Mol Biomed. 2024. PMID: 39333445 Free PMC article. Review.

6

Efficient use of binned data for imputing univariate time series data.

Darji J, Biswas N, Padul V, Gill J, Kesari S, Ashili S. Darji J, et al. Among authors: ashili s. Front Big Data. 2024 Aug 21;7:1422650. doi: 10.3389/fdata.2024.1422650. eCollection 2024. Front Big Data. 2024. PMID: 39234189 Free PMC article.

7

Drug delivery in leptomeningeal disease: Navigating barriers and beyond.

Arshad N, Biswas N, Gill J, Kesari S, Ashili S. Arshad N, et al. Among authors: ashili s. Drug Deliv. 2024 Dec;31(1):2375521. doi: 10.1080/10717544.2024.2375521. Epub 2024 Jul 12. Drug Deliv. 2024. PMID: 38995190 Free PMC article. Review.

8

Nanoparticle-mediated active and passive drug targeting in oral squamous cell carcinoma: current trends and advances.

Manikkath J, Manikkath A, Lad H, Vora LK, Mudgal J, Shenoy RR, Ashili S, Radhakrishnan R. Manikkath J, et al. Among authors: ashili s. Nanomedicine (Lond). 2023 Nov;18(27):2061-2080. doi: 10.2217/nnm-2023-0247. Epub 2024 Jan 10. Nanomedicine (Lond). 2023. PMID: 38197397 Review.

9

Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines.

Lin F, Lin EZ, Anekoji M, Ichim TE, Hu J, Marincola FM, Jones LD, Kesari S, Ashili S. Lin F, et al. Among authors: ashili s. J Transl Med. 2023 Nov 18;21(1):830. doi: 10.1186/s12967-023-04724-0. J Transl Med. 2023. PMID: 37978542 Free PMC article. Review.

10

MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies.

Dhas Y, Arshad N, Biswas N, Jones LD, Ashili S. Dhas Y, et al. Among authors: ashili s. Biomedicines. 2023 Sep 20;11(9):2583. doi: 10.3390/biomedicines11092583. Biomedicines. 2023. PMID: 37761024 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters